Lysophosphatidylcholine Stimulates MAP Kinase Activity in Rat Vascular Smooth Muscle Cells

Hypertension

Volumn 31, Issue 1, 1998, Pages 248-253

  Yamakawa, Tadashi ^a   Eguchi, Satoru ^a   Yamakawa, Yuko ^a   Motley, Evangeline D ^a   Numaguchi, Kotaro ^a   Utsunomiya, Hirotoshi ^a   Inagami, Tadashi ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 [1 (3 DIMETHYLAMINOPROPYL) 3 INDOLYL] 3 (3 INDOLYL)MALEIMIDE; CALCIUM ION; EGTAZIC ACID; LYSOPHOSPHATIDYLCHOLINE; MITOGEN ACTIVATED PROTEIN KINASE; PERTUSSIS TOXIN; PHORBOL 13 ACETATE 12 MYRISTATE; PROTEIN KINASE C INHIBITOR; PROTEIN KINASE INHIBITOR; TRANSCRIPTION FACTOR AP 1; MESSENGER RNA; PROTEIN C FOS; PROTEIN C JUN; PROTEIN KINASE (CALCIUM,CALMODULIN);

ANIMAL CELL; ARTICLE; CELL CULTURE; CONTROLLED STUDY; DNA BINDING; DOWN REGULATION; ENZYME ACTIVITY; GENE EXPRESSION; HYPERTENSION; NONHUMAN; ONCOGENE C FOS; ONCOGENE C JUN; PHOSPHOLIPID METABOLISM; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION; VASCULAR SMOOTH MUSCLE; ANIMAL; BIOSYNTHESIS; CELL NUCLEUS; CYTOLOGY; DRUG EFFECT; ENZYME ACTIVATION; GENETIC TRANSCRIPTION; METABOLISM; ONCOGENE; SPRAGUE DAWLEY RAT; THORACIC AORTA;

ANIMALS; AORTA, THORACIC; CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE; CELL NUCLEUS; CELLS, CULTURED; ENZYME ACTIVATION; GENES, FOS; GENES, JUN; LYSOPHOSPHATIDYLCHOLINES; MUSCLE, SMOOTH, VASCULAR; PROTO-ONCOGENE PROTEINS C-FOS; PROTO-ONCOGENE PROTEINS C-JUN; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; TRANSCRIPTION FACTOR AP-1; TRANSCRIPTION, GENETIC;

EID: 0031611275     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/01.HYP.31.1.248     Document Type: Article

References (35)

1. 2 in the pathology of disease. Lab Invest. 1986;55:391-404.
2. 2 activity in endothelial cell-induced modification of low density lipoprotein. Proc Natl Acad Sci U S A. 1985;82:3000-3004.
3. Kume N, Cybulsky MI, Gimbrone MJ. Lysophosphatidylcholine, a component of atherogenic lipoproteins, induces mononuclear leukocyte adhesion molecules in cultured human and rabbit arterial endothelial cells. J Clin Invest. 1992;90:1138-1144.
4. Kume N, Gimbrone MJ. Lysophosphatidylcholine transcriptionally induces growth factor gene expression in cultured human endothelial cells. J Clin Invest. 1994;93:907-911.
5. Kugiyama K, Kerns SA, Morrisett JD, Roberts R, Henry PD. Impairment of endothelium-dependent arterial relaxation by lysolecithin in modified low-density lipoproteins. Nature. 1990;344:160-162.
6. Liu SY, Lu X, Choy S, Dembinski TC, Hatch GM, Mymin D, Shen X, Angel A, Choy PC, Man RY. Alteration of lysophosphatidylcholine content in low density lipoprotein after oxidative modification: relationship to endothelium dependent relaxation. Cardiovasc Res. 1994;28:1476-1481.
7. Murohara T, Kugiyama K, Ohgushi M, Sugiyama S, Ohta Y, Yasue H. LPC in oxidized LDL elicits vasocontraction and inhibits endothelium-dependent relaxation. Am J Physiol. 1994;267:H2441-H2449.
8. 2+ influx, enhanced DNA synthesis and cytotoxicity in cultured vascular smooth muscle cells. Atherosclerosis. 1995;112:69-76.
9. Chai YC, Howe PH, DiCorleto PE, Chisolm GM. Oxidized low density lipoprotein and lysophosphatidylcholine stimulate cell cycle entry in vascular smooth muscle cells. Evidence for release of fibroblast growth factor-2. J Biol Chem. 1996;271:17791-17797.
10. Blenis J. Signal transduction via the MAP kinases: proceed at your own RSK. Proc Natl Acad Sci U S A. 1993;90:5889-5892.
11. Cobb MH, Goldsmith EJ. How MAP kinases are regulated. J Biol Chem. 1995;270:14843-14846.
12. Pelech SL, Sanghera JS. MAP kinases: charting the regulatory pathways. Science. 1993;257:1355-1356.
13. Eguchi S, Hirata Y, Imai T, Kanno K, Marumo F. Phenotypic change of endothelial receptor subtype in cultured rat vascular smooth muscle cells. Endocrinology. 1994;134:222-228.
14. Dignam JD, Lebowitz RM, Roeder RG. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res. 1983;11:1475-1489.
15. Chomczynski P, Sacchi N. Single step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987;162:156-159.
16. Hirata Y, Emori T, Eguchi S, Kanno K, Imai T, Ohta K, Marumo F. Endothelin receptor subtype B mediates synthesis of nitric oxide by cultured bovine endothelial cells. J Clin Invest. 1993;91:1367-1373.
17. Tokumura A, Harada K, Fukuzawa K, Tsukatani H. Involvement of lysophosphohpase D in the production of lysophosphatidic acids in rat plasma. Biochim Biophys Acta. 1986;875:31-38.
18. ras pathway. J Biol Chem. 1994;269:645-651.
19. Cook SJ, Rubinfeld B, Albert I, McCormick F. RapV12 antagonizes Ras-dependent activation of ERK 1 and ERK 2 by LPA and EGF in Rat-1 fibroblasts. EMBO J. 1993;12:3475-3485.
20. raf-1. J Biol Chem. 1993;268:20717-20720.
21. 2 in signal transduction through protein kinase C. Proc Natl Acad Sci U S A. 1992;89:6447-6451.
22. 2 in T-lymphocyte activation: implication in propagation of inflammatory reaction. Proc Natl Acad Sci U S A. 1993;90:716-719.
23. 2 in HL-60 cell differentiation to macrophages induced by protein kinase C activation. Proc Natl Acad Sci U S A. 1993;90:4917-4922.
24. Jalink K, Hordijk PL, Moolenaar WH. Growth factor-like effects of lysophosphatidic acid, a novel mediator. Biochim Biophys Acta. 1994;1198:185-196.
25. Moolenaar WH. Lysphosphatidic acid: a multifunctional phospholipid messenger. J Biol Chem. 1995;270:12949-12952.
26. Moolenaar WH. Lysophosphatidic acid signaling. Curr Opin Cell Biol. 1995;7:203-210.
27. Seewald S, Sachinidis A, Dusing R, Ko Y, Seul C, Epping P, Vetter H. Lysophosphatidic acid and intracellular signaling in vascular smooth muscle cells. Atherosclerosis. 1997;130:121-131.
28. Tokumura A, Iimori M, Nishioka Y, Kitahara M, Sakashita M, Tanaka S. Lysophosphatidic acids induce proliferation of cultured vascular smooth muscle cells from rat aorta. Am J Physiol. 1994;267:C204-C210.
29. Kugiyama K, Ohgushi M, Sugiyama S, Murohara T, Fukunaga K, Miyamoto E, Yasue H. Lysophosphatidylcholine inhibits surface receptor-mediated intracellular signals in endothelial cells by a pathway involving protein kinase C activation. Circ Res. 1992;71:1422-1428.
30. Kolch W, Heidecker G, Kochs G, Hummel R, Vahidi H, Mischak H, Finkencellar G, Marne D, Rapp UR. Protein kinase C alpha activates Raf-1 by direct phosphorylation. Nature. 1993;364:249-251.
31. Toullec D, Pianetti P, Coste H, Bellevergue P, Grand-Perret T, Ajakane M, Baudet V, Boissin P, Boursier E, Loriolle F, Duhamel L, Charon D, Kirilovsky J. The bisindolysmaleimide GF 109203X is a potent and selective inhibitor of protein kinase C. J Biol Chem. 1991;266:15771-15781.
32. Eguchi S, Matsumoto T, Motley ED, Utsunomiya H, Inagami T. Identification of an essential signaling cascade for mitogen-activated protein kinase activation by angiotensin II in cultured rat vascular smooth muscle cells. J Biol Chem. 1996;271:14169-14175.
33. Esterbauer H, Gebicki J, Puhl H. Jurgens G. The role of lipid peroxidation and antioxidants in oxidative modification of LDL. Free Radic Biol Med. 1992;13:341-390.
34. Deigner HP, Claus R. Stimulation of mitogen activated protein kinase by LDL and oxLDL in human U-937 macrophage-like cells. FEBS Lett. 1996;385:149-153.
35. Kusuhara M, Chait A, Cader A, Berk BC. Oxidized LDL stimulates mitogen-activated protein kinases in smooth muscle cells and macrophages. Arterioscler Thromb Vasc Biol. 1997;17:141-148.